We hypothesized that recapitulating a molecular event that occurs during natural aging at the onset of sarcopenia, such as Atrogin-1 expression, would be an efficient and biologically relevant strategy for inducing muscle atrophy and degeneration. Here, FBXO32 is linked to sarcopenia.